You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MIB-1 (Ki-67) Rate

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

Not yet recruiting
  • Breast Cancer
  • Cancer of the Breast
  • VENTANA MIB-1 Ki67 assay
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 18, 2023

Neuroendocrine Tumor Trial in Beijing (PM8002, FOLFIRI)

Recruiting
  • Neuroendocrine Neoplasm
  • Beijing, China
    Chinese PLA General Hospital
May 25, 2023

Breast Cancer Trial in Shijiazhuang (Dalpiciclib, Aromatase inhibitor, Docetaxel injection)

Recruiting
  • Breast Cancer
  • Shijiazhuang, Hebei, China
    The Fourth Hospital of Hebei Medical University
Oct 25, 2023

Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)

Recruiting
  • Premenopausal Breast Cancer
  • Hormone Receptor-positive Breast Cancer
  • Tamoxifen Oral Product
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 14, 2022

Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • +6 more
  • (no location specified)
Aug 4, 2023

Friedreich Ataxia Trial in Philadelphia (MIB-626)

Active, not recruiting
  • Friedreich Ataxia
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Oct 26, 2022

Breast Tumors, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in United States (Z-endoxifen, exemestane,

Recruiting
  • Breast Neoplasms
  • +3 more
  • Phoenix, Arizona
  • +3 more
Jan 30, 2023

Breast Cancer Trial in Kansas City (Letrozole, Placebo)

Completed
Has Results
  • Breast Cancer
  • Kansas City, Kansas
    University of Kansas Medical Center
Jan 9, 2022

Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)

Active, not recruiting
  • Breast Cancer
  • +2 more
  • New York, New York
    Columbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022

EBV-positive Gastric Cancer and Multiple Genes Associated With

Completed
  • Gastric Cancer
  • +2 more
  • Gastrectomy
  • Suwon, Gyeong-Gi-Do, Korea, Republic of
    Jiwon Seo
Oct 28, 2022

Breast Cancer Trial (tibolone, )

Completed
  • Breast Cancer
  • (no location specified)
Feb 2, 2022

Healthy Trial (Investigational Product - MIB 626, Placebo, Standardized, progressive, high intensity, multidimensional exercise)

Not yet recruiting
  • Healthy
  • Investigational Product - MIB 626
  • +3 more
  • (no location specified)
Jun 1, 2023

Breast Cancer Trial in Lisboa (Aerobic Training Group, Resistance Training Group, Control group)

Not yet recruiting
  • Breast Cancer
  • Aerobic Training Group
  • +2 more
  • Lisboa, Portugal
    Fundação Champalimaud
Jul 25, 2022

Breast Carcinoma; Magnetic Resonance Imaging;OGSE Trial in Guangzhou (Gradient and pulse imaging)

Not yet recruiting
  • Breast Carcinoma; Magnetic Resonance Imaging；OGSE
  • Gradient and pulse imaging
  • Guangzhou, Guangdong, China
    Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-
May 10, 2022

Female Breast Cancer Trial in Germany

Recruiting
  • Female Breast Cancer
    • Moenchengladbach, NRW, Germany
    • +4 more
    Mar 30, 2023

    Risk Reduction, Breast Cancer Trial in United States (Bazedoxifene and Conjugated Estrogens)

    Recruiting
    • Risk Reduction
    • Breast Cancer
    • Bazedoxifene and Conjugated Estrogens
    • Duarte, California
    • +4 more
    Feb 14, 2022

    Alzheimer's Disease (Incl Subtypes), Dementia Trial in Boston (MIB-626, Placebo)

    Recruiting
    • Alzheimer's Disease (Incl Subtypes)
    • Dementia
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 11, 2022

    Neuroendocrine Tumors Trial in Toronto (F18-FDG)

    Recruiting
    • Neuroendocrine Tumors
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    May 20, 2022

    Oral Leukoplakia Trial in Minneapolis (pioglitazone-metformin)

    Not yet recruiting
    • Oral Leukoplakia
    • Minneapolis, Minnesota
      University of Minnesota
    Feb 4, 2023

    Brain Tumor, Cervical Cancer Trial in Houston (18F-FTX)

    Recruiting
    • Brain Tumor
    • Cervical Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 9, 2022

    MammaPrint Value for Pre-menopausal Breast Cancer Patients

    Recruiting
    • Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 25, 2022

      Cervix Dysplasia, HPV Infection Trial in Herne (DEFLAGYN vaginal gel)

      Not yet recruiting
      • Cervix Dysplasia
      • HPV Infection
      • DEFLAGYN vaginal gel
      • Herne, North Rhine-Westphalia, Germany
        Marien Hospital Herne
      Aug 19, 2022

      Neuroendocrine Tumors, Neuroendocrine Carcinoma, Temozolomide Trial in Seoul (TEMCAP)

      Active, not recruiting
      • Neuroendocrine Tumors
      • +3 more
      • Seoul, Korea, Republic of
        Asan Medical Center, University of Ulsan College of Medicine
      Dec 13, 2020

      Breast Cancer Trial in Omaha (Palbociclib 125mg)

      Recruiting
      • Breast Cancer
      • Palbociclib 125mg
      • Omaha, Nebraska
        Nebraska Medicine
      Mar 3, 2022

      Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

      Not yet recruiting
      • Breast Cancer
      • +3 more
      • (no location specified)
      Aug 4, 2023